Primary tumour resection and survival in the palliative management of metastatic colorectal cancer

European Journal of Surgical Oncology

Volumn 35, Issue 2, 2009, Pages 164-167

  Bajwa, A ^a   Blunt, N ^a   Vyas, S ^a   Suliman, I ^a   Bridgewater, J ^b   Hochhauser, D ^b   Ledermann, J A ^b   O'Bichere, A ^a  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Colorectal cancer; Metastatic; Palliative; Primary tumour; Resection

Indexed keywords

CAPECITABINE; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN;

ADULT; AGED; ARTICLE; BLEEDING; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER PALLIATIVE THERAPY; CANCER SURGERY; CANCER SURVIVAL; COLORECTAL CANCER; FEMALE; HUMAN; INTESTINE OBSTRUCTION; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; SURVIVAL TIME;

AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; DIGESTIVE SYSTEM SURGICAL PROCEDURES; FEMALE; FOLLOW-UP STUDIES; GREAT BRITAIN; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; PALLIATIVE CARE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 58149483576     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2008.06.005     Document Type: Article

References (22)

1. Cook A.D., Single R., and McCahill L.E. Surgical resection of primary tumors in patients who present with stage IV colorectal cancer: an analysis of surveillance, epidemiology, and end results data, 1988 to 2000. Ann Surg Oncol 12 8 (2005) 637-645
2. Martin R., Paty P., Fong Y., et al. Simultaneous liver and colorectal resections are safe for synchronous colorectal liver metastasis. J Am Coll Surg 197 2 (2003) 233-241
3. Zampino M.G., Magni E., Massacesi C., et al. First clinical experience of orally active epidermal growth factor receptor inhibitor combined with simplified FOLFOX6 as first-line treatment for metastatic colorectal cancer. Cancer 110 4 (2007) 752-758
4. Tournigand C., Andre T., Achille E., et al. FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study. J Clin Oncol 22 2 (2004) 229-237
5. Smothers L., Hynan L., Fleming J., Turnage R., Simmang C., and Anthony T. Emergency surgery for colon carcinoma. Dis Colon Rectum 46 1 (2003) 24-30
6. Cummins E.R., Vick K.D., and Poole G.V. Incurable colorectal carcinoma: the role of surgical palliation. Am Surg 70 5 (2004) 433-437
7. Ruo L., Gougoutas C., Paty P.B., Guillem J.G., Cohen A.M., and Wong W.D. Elective bowel resection for incurable stage IV colorectal cancer: prognostic variables for asymptomatic patients. J Am Coll Surg 196 5 (2003) 722-728
8. Tebbutt N.C., Norman A.R., Cunningham D., et al. Intestinal complications after chemotherapy for patients with unresected primary colorectal cancer and synchronous metastases. Gut 52 4 (2003) 568-573
9. Michel P., Roque I., Di Fiore F., et al. Colorectal cancer with non-resectable synchronous metastases: should the primary tumor be resected?. Gastroenterol Clin Biol 28 5 (2004) 434-437
10. Sarela A.I., Guthrie J.A., Seymour M.T., Ride E., Guillou P.J., and O'Riordain D.S. Non-operative management of the primary tumour in patients with incurable stage IV colorectal cancer. Br J Surg 88 10 (2001) 1352-1356
11. Nordic Gastrointestinal Tumor Adjuvant Therapy Group. Expectancy or primary chemotherapy in patients with advanced asymptomatic colorectal cancer: a randomized trial. J Clin Oncol 10 6 (1992) 904-911
12. Alley P.G., and McNee R.K. Age and sex differences in right colon cancer. Dis Colon Rectum 29 4 (1986) 227-229
13. Wu C.S., Tung S.Y., Chen P.C., and Kuo Y.C. Clinicopathological study of colorectal mucinous carcinoma in Taiwan: a multivariate analysis. J Gastroenterol Hepatol 11 1 (1996) 77-81
14. Nozoe T., Anai H., Nasu S., and Sugimachi K. Clinicopathological characteristics of mucinous carcinoma of the colon and rectum. J Surg Oncol 75 2 (2000) 103-107
15. Kanemitsu Y., Kato T., Hirai T., et al. Survival after curative resection for mucinous adenocarcinoma of the colorectum. Dis Colon Rectum 46 2 (2003) 160-167
16. Benoist S., Pautrat K., Mitry E., Rougier P., Penna C., and Nordlinger B. Treatment strategy for patients with colorectal cancer and synchronous irresectable liver metastases. Br J Surg 92 9 (2005) 1155-1160
17. Douillard J.Y., Cunningham D., Roth A.D., et al. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial. Lancet 355 9209 (2000) 1041-1047
18. Temple L.K., Hsieh L., Wong W.D., Saltz L., and Schrag D. Use of surgery among elderly patients with stage IV colorectal cancer. J Clin Oncol 22 17 (2004) 3475-3484
19. Rapiti E., Verkooijen H.M., Vlastos G., et al. Complete excision of primary breast tumor improves survival of patients with metastatic breast cancer at diagnosis. J Clin Oncol 24 18 (2006) 2743-2749
20. Flanigan R.C., and Yonover P.M. The role of radical nephrectomy in metastatic renal cell carcinoma. Semin Urol Oncol 19 2 (2001) 98-102
21. Samarasam I., Chandran B.S., Sitaram V., Perakath B., Nair A., and Mathew G. Palliative gastrectomy in advanced gastric cancer: is it worthwhile?. ANZ J Surg 76 1-2 (2006) 60-63
22. Oken M.M., Creech R.H., Tormey D.C., et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5 6 (1982) 649-655